David B. Singer is Managing Partner of Maverick Ventures.  He joined Maverick in 2004.  Mr. Singer is a founder and former CEO of three healthcare companies:  Affymetrix, Inc., Corcept Therapeutics, Inc. and Genesoft Pharmaceuticals, Oscient’s predecessor.   Mr. Singer currently serves on the boards of several private companies in the fields of healthcare information technology, healthcare delivery, and biotechnology.  He currently serves on the board of Castlight Health (NYSE: CSLT), and has served on the boards of several public companies, including the three companies he founded.

Mr. Singer received a B.A. from Yale University and an M.B.A. from Stanford University.  Previously, he was a Crown Fellow of the Aspen Institute and a member of the Rand Corporation’s Health Advisory Board.   He is currently a Sterling Fellow of Yale University, Vice Chair of College Track and Vice President of the San Francisco Health Commission.